Latest Proof Snapshot
Q1 2026 (reported 21 April 2026) is the freshest investment evidence, and it reads as a strong-demand quarter that should not be annualized. Reported diluted EPS rose 32% year over year to $1.51 and adjusted diluted EPS rose 21% to $1.78, helped in part by an easy prior-year comparison; company-reported free cash flow rose 65% to $1.309 bn after $546 mn of capex, though that is a figure. Backlog climbed to $271 bn from $268 bn at year-end 2025 despite $22.076 bn of sales, with defense bookings near $14 bn versus about $9 bn a year earlier, so book-to-bill ran modestly above 1. Segment execution was broad: Collins posted $7.602 bn of sales at a 17.2% reported operating margin, Pratt $8.173 bn at 8.7%, and Raytheon $6.945 bn at 12.1%. The valuation question is whether this order-and-revenue strength becomes recurring post-capex cash, not whether a single quarter looked good.